# OnCo record nct04486378 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct04486378/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct04486378", "NCT04486378" ;
  schema:name "A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer"@en ;
  schema:description "A phase 2 trial of RO7198457 intravenous (IV) in colorectal cancer, run by BioNTech SE, active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct04486378/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04486378> ;
  onco:status "active" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2021-03-08" ;
  onco:cancers <https://onco.cc/cancers/colorectal/> ;
  onco:companies <https://onco.cc/companies/biontech/>, <https://onco.cc/companies/flatiron-health/> .
